Aeterna Zentaris Abstract Accepted for Presentation at 13th International Congress on Autoimmunity
11. April 2022 08:05 ET
|
Aeterna Zentaris Inc
– Company to present regarding AIM Biologicals as a potential therapeutic treatment option for neuromyelitis optica spectrum disorder ("NMOSD"), an orphan indication with strong unmet medical need ...